Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.

Novo Nordisk is also pairing the long-acting insulin with its once-weekly GLP-1 agonist semaglutide in the COMBINE trials programme, which is due to complete in 2024, is also working on a glucose ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Nearly 150 new Florida laws went into effect July 1 and some of them make big changes you need to know. Here's the list.

Humulin N isn’t a type of regular insulin. Regular insulins are typically short-acting insulins, which take about 30 minutes to start working after they’re injected.

Dr. Perrier: "We are getting closer to the goal of developing a standard treatment for diabetes that could one day make ...

A global research team, led by Wake Forest University’s Dr. Quentin Perrier, has successfully 3D-printed functioning human ...

CHICAGO — Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for patients with overweight or obesity in an early study ...

See the latest Novo Nordisk AS ADR stock price (NVO:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

UNESCO World Heritage CentreRhaetian Railway in the Albula / Bernina Landscapes, brings together two historic railway lines that cross the Swiss Alps through two passes. Opened in 1904, the Albula ...